Editor's Note The US Food and Drug Administration (FDA) announced on July 6 that it would alter its emergency use authorization for the Paxlovid pill—Pfizer’s oral antiviral pill used by some to treat COVID-19—to allow pharmacists to prescribe the treatment to recently affected individuals directly. According to Fierce Pharma July…